Henry R. Kravis, 10% Owner at IMPEL NEUROPHARMA INC (IMPL), bought 3,802,638 shares at $15.00 ($18.1M) on 2021-04-27, disclosed to the SEC on 2021-04-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,583,926 | $0 | 0.0% |
| 2 | $13.50 | 118,712 | $1.6M | 8.9% |
| 3 | $15.00 | 1,100,000 | $16.5M | 91.1% |
| Total | $4.76 avg | 3,802,638 | $18.1M | 100% |
| Filing → |
| BBIO | SELL | 2025-05-14 | $410.4M | — | Filing → |
| APP | SELL | 2024-11-25 | $3.3B | — | Filing → |
| APP | SELL | 2023-08-16 | $370.0M | — | Filing → |